Indefinite Delivery Contract HHSN271201700009I
Award Date 3/31/17
Last Date to Order 3/31/24
Funding Federal Agency
Contracting Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
Pricing Type
Order Dependent (IDV only)
Legislative Mandate
Not listed National Interest Action
None
Award Type
Multiple
Primary Consortia Member
Not listed Similar IDVs
- The Department of Health and Human Services' National Center for Advancing Translational Sciences (NCATS) has issued a multiple-award Indefinite Delivery/Indefinite Quantity (IDIQ) contract valued at up to $49,885,703 to support Chemistry, Manufacturing, and Control (CMC) services for drug product development. The 7-year contract was awarded to Fisher Bioservices Inc.'s Clinical Trials Division, a subsidiary of Thermo Electron Corporation. The contract scope includes a wide range of CMC services...
- The Department of Health and Human Services' National Institutes of Health (NIH) National Center for Advancing Translational Sciences (NCATS) has awarded a single-award indefinite delivery contract to Polypeptide Laboratories San Diego, LLC, a Contract Development & Manufacturing Organization (CDMO), to provide chemistry, manufacturing, and controls (CMC) services for the development of drug substances. This five-year, $49.7 million IDV contract, awarded without set-asides, supports NCATS'...
- This Indefinite Delivery Contract (IDC) was awarded by the Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Center for Advancing Translational Sciences (NCATS) to PPD Development LP, a global contract research organization (CRO). The contract has a total potential value of $3,912,150 and provides comprehensive, integrated drug development, laboratory, and lifecycle management services to support NCATS' bioanalytical method development programs. This...
- The federal contract IDV award is for Chemistry, Manufacturing, and Control (CMC) and related services to support the development of drug products for the National Center for Advancing Translational Sciences (NCATS), a civilian agency. This is a multiple award, indefinite delivery contract with a $49,885,703 ceiling value and a period of performance through July 2031. The prime contractor, Alchem Laboratories Corporation, is a for-profit pharmaceutical manufacturer that will provide a broad...
- The National Center for Advancing Translational Sciences (NCATS), a civilian agency within the Department of Health and Human Services, awarded an Indefinite Delivery Contract (IDC) valued up to $17,887,012 to Organix Chemistry Solutions LLC for CRO Support for NCATS Medicinal Chemistry for Lead Optimization. Under this multiple-award IDC, Organix was issued two delivery orders to date. The first delivery order, valued at $3,677,412.09, provides synthetic chemistry support services to NCATS'...
- This indefinite delivery contract (IDC) was awarded by the National Center for Advancing Translational Sciences (NCATS), a civilian agency within the U.S. Department of Health and Human Services, to Alchem Laboratories Corporation. The contract, valued at up to $17,891,012, is to provide CRO (contract research organization) support services for NCATS's Medicinal Chemistry for Lead Optimization program. Under this multiple-award IDC, Alchem Laboratories will perform a variety of preclinical and...
- This indefinite delivery contract was awarded by the National Center for Advancing Translational Sciences (NCATS), a civilian agency within the Department of Health and Human Services, to Eurofins Discovery Services North America, LLC, a foreign-owned for-profit contract research organization. The $17,891,012 multiple-award contract, which runs through April 2025, is for CRO support services related to NCATS' medicinal chemistry program for lead optimization. The initial $1,000...
- This federal contract IDV award is for CRO (Contract Research Organization) support for medicinal chemistry lead optimization programs managed by the National Center for Advancing Translational Sciences (NCATS), which is part of the National Institutes of Health (NIH) within the Department of Health and Human Services. The prime contractor, SRI International, is a large non-profit research and development organization with a significant history of providing advanced scientific and technical...
- The federal contract IDV award is for CRO (Contract Research Organization) support services for medicinal chemistry lead optimization programs at the National Center for Advancing Translational Sciences (NCATS), a civilian agency within the Department of Health and Human Services. The prime contractor is Southwest Research Institute (SwRI), a non-profit research and development organization, which was awarded the $17,891,012 multiple-award Indefinite Delivery Contract without any set-aside...
- This indefinite delivery contract was awarded by the National Center for Advancing Translational Sciences (NCATS), part of the U.S. Department of Health and Human Services, to Lovelace Biomedical Research Institute, a not-for-profit contract research organization based in Albuquerque, New Mexico. The $17.89 million multiple-award contract, which runs through April 2025, is for contract research organization (CRO) support for NCATS' medicinal chemistry work focused on lead optimization. Under the...
- HHSN271201700009IIndefinite Delivery Contract
- 3Federal Contract Awards
PARENT IDIQ AWARD: CRO SUPPORT FOR NCATS DRUG SUBSTANCE DEVELOPMENT AND MANUFACTURE
Posted 3/31/17
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00004 | Other Administrative Action | $0 | 3/24/22 | |
| P00003 | Other Administrative Action | $0 | 3/24/22 | |
| P00002 | Funding Only Action | ($5k) | 1/4/22 | |
| P00001 | Other Administrative Action | $0 | 7/27/20 | |
| Not listed | Not listed | $5.0k | 3/31/17 |
Name | Description | Awardee | Potential Value | AwardDate | CompletionDate | Updated At |
|---|---|---|---|---|---|---|
Delivery Order HHSN271201700009I-75N95020F00001 | Bachem Americas Inc. | $1.1m | 8/4/20 | 8/3/24 | 5/1/25 | |
Delivery Order HHSN271201700009I-75N95022F00001 | Bachem Americas Inc. | $597.4k | 3/29/22 | 3/28/26 | 3/10/23 | |
Delivery Order HHSN271201700009I-75N95020F00002 | Bachem Americas Inc. | $827.8k | 9/18/20 | 8/31/24 | 1/26/22 |
Name | Description | Solicitation Number | FederalAgency | Type | PostedDate |
|---|---|---|---|---|---|
CRO Support for NCATS Drug Substance Development and Manufacture | N01TR-17-2001 | Department of Health and Human Services National Institutes of Health | Award Notice 1/1 | 3/1/16, 11:41 AM |